The FDA Just Approved “Viagra for Women”

Flibanserin, a drug to treat low sexual desire in women. Allen Breed/AP

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


More than 17 years after it ushered in Viagra, the Federal Drug Administration approved the first women’s sex-drive drug, flibanserin, earlier today.  Sprout Pharmaceuticals will manufacture the drug, which they’ve named Addyi, and sell it to women with low libido, or hypoactive sexual desire disorder (HSDD).

While the pill has garnered much attention under monikers like “pink Viagra” or “Viagra for women,” its purpose and mechanism have little in common with the famous blue pill for men. The drug will not physically bring blood to parts of the body to assist arousal, but instead will alter chemicals in the brain to increase sexual desire.

Is this a victory for women after decades of being ignored by biased pharmaceutical researchers?

Well, not necessarily. As we reported in June:

Women who took the drug in trials reported no more than one additional “sexually satisfying event” per month than women who received a placebo.

Not a great track record. Many health experts and academics doubt the existence of HSDD and believe Big Pharma is fabricating a disorder and exploiting gender imbalances to create a new market. Private investors staked some $50 million on flibanserin’s approval, according to Forbes.

The FDA’s decision came after two prior rejections of the drug because of side effects like dry mouth, fatigue, nausea, and fainting. On the bright side, consumers of Addyi ready to jump into bed will be relieved to hear that the side effects have apparently been diminished.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate